Genomic mechanisms of acquired resistance of patients (pts) with BRAF V600E-mutant (mt) metastatic colorectal cancer (mCRC) treated in the BEACON study

by on 23 de gener de 2023 with No hi ha comentaris
  • Kopetz, S., Murphy, D. A., Pu, J., Yaeger, R., Ciardiello, F., Desai, J., . . . Tabernero, J. (2022). Genomic mechanisms of acquired resistance of patients (pts) with BRAF V600E-mutant (mt) metastatic colorectal cancer (mCRC) treated in the BEACON study. Annals of Oncology, 33(7), S681-S682. https://doi.org/10.1016/j.annonc.2022.07.454 (Meeting abstract)

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *